Dyskinesia, Drug-Induced (epidemiology) < Dyskinesia, Drug-Induced (etiology) < Dyskinesia, Drug-Induced (genetics)

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 35.
[0-20] [0 - 20][0 - 35][20-34][20-40]

Ident.	Authors (with country if any)	Title
000086 (2000)	L L Trépanier [Canada] ; R. Kumar ; A M Lozano ; A E Lang ; J A Saint-Cyr	Neuropsychological outcome of GPi pallidotomy and GPi or STN deep brain stimulation in Parkinson's disease.
000326 (2003)	A Jon Stoessl [Canada]	Agonizing over dopaminergic replacement therapy--lessons from animal models of Parkinson's disease.
000378 (2003)	Nancy Bélanger [Canada] ; Laurent Grégoire ; Abdallah Hadj Tahar ; Paul J. Bédard	Chronic treatment with small doses of cabergoline prevents dopa-induced dyskinesias in parkinsonian monkeys.
000404 (2004)	Raúl De La Fuente-Fernández [Canada] ; Michael Schulzer ; Edwin Mak ; Donald B. Calne ; A Jon Stoessl	Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model.
000405 (2004)	Harold D. Foster [Canada] ; Abram Hoffer	The two faces of L-DOPA: benefits and adverse side effects in the treatment of Encephalitis lethargica, Parkinson's disease, multiple sclerosis and amyotrophic lateral sclerosis.
000449 (2004)	Raúl De La Fuente-Fernández [Canada] ; Vesna Sossi ; Zhigao Huang ; Sarah Furtado ; Jian-Qiang Lu ; Donald B. Calne ; Thomas J. Ruth ; A Jon Stoessl	Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias.
000459 (2004)	Yoshiaki Furukawa [Canada] ; James J. Filiano ; Stephen J. Kish	Amantadine for levodopa-induced choreic dyskinesia in compound heterozygotes for GCH1 mutations.
000617 (2006)	Francesca Morgante [Canada] ; Alberto J. Espay ; Carolyn Gunraj ; Anthony E. Lang ; Robert Chen	Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias.
000618 (2006)	Vesna Sossi [Canada] ; Raúl De La Fuente-Fernández ; Michael Schulzer ; John Adams ; Jon Stoessl	Age-related differences in levodopa dynamics in Parkinson's: implications for motor complications.
000640 (2006)	Mehrdad Ghassemi [Canada] ; Sarah Lemieux ; Mandar Jog ; Roderick Edwards ; Christian Duval	Bradykinesia in patients with Parkinson's disease having levodopa-induced dyskinesias.
000670 (2006)	Pershia Samadi [Canada] ; Paul J. Bédard ; Claude Rouillard	Opioids and motor complications in Parkinson's disease.
000678 (2007)	Sarah Lemieux [Canada] ; Mehrdad Ghassemi ; Mandar Jog ; Roderick Edwards ; Christian Duval	The influence of levodopa-induced dyskinesias on manual tracking in patients with Parkinson's disease.
000801 (2007)	Jackie Gour [Canada] ; Roderick Edwards ; Sarah Lemieux ; Mehrdad Ghassemi ; Mandar Jog ; Christian Duval	Movement patterns of peak-dose levodopa-induced dyskinesias in patients with Parkinson's disease.
000849 (2008)	Alison Fenney [Canada] ; Mandar S. Jog ; Christian Duval	Short-term variability in amplitude and motor topography of whole-body involuntary movements in Parkinson's disease dyskinesias and in Huntington's chorea.
000952 (2008)	Susan H. Fox [Canada] ; Rosalind Chuang ; Jonathan M. Brotchie	Parkinson's disease--opportunities for novel therapeutics to reduce the problems of levodopa therapy.
000A48 (2009)	Pershia Samadi [Canada] ; Alex Rajput ; Frédéric Calon ; Laurent Grégoire ; Oleh Hornykiewicz ; Ali H. Rajput ; Thèrèse Di Paolo	Metabotropic glutamate receptor II in the brains of Parkinsonian patients.
000F58 (2011)	Tejas Sankar [Canada] ; Andres M. Lozano	Surgical approach to l-dopa-induced dyskinesias.
001179 (2012)	Behzad Elahi [Canada] ; Nicolás Phielipp ; Robert Chen	N-Methyl-D-Aspartate antagonists in levodopa induced dyskinesia: a meta-analysis.
001353 (2013)	James B. Koprich [Canada] ; Philippe Huot ; Susan H. Fox ; Keith Jarvie ; Anthony E. Lang ; Philip Seeman ; Jonathan M. Brotchie	The effects of fast-off-D2 receptor antagonism on L-DOPA-induced dyskinesia and psychosis in parkinsonian macaques.
001357 (2013)	Philippe Huot [Canada] ; Tom H. Johnston ; James B. Koprich ; Susan H. Fox ; Jonathan M. Brotchie	The pharmacology of L-DOPA-induced dyskinesia in Parkinson's disease.
001868 (2014)	I A Prescott [Canada] ; L D Liu [Canada] ; J O Dostrovsky [Canada] ; M. Hodaie [Canada] ; A M Lozano [Canada] ; W D Hutchison [Canada]	Lack of depotentiation at basal ganglia output neurons in PD patients with levodopa-induced dyskinesia.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Dyskinesia, Drug-Induced (etiology)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Dyskinesia, Drug-Induced (etiology)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Dyskinesia, Drug-Induced (etiology)
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022